-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Novel Diagnostic Genomic Tools and Technologies

PhD Trainee
Program: Scientific Workshops @ ASH
Thursday, December 3, 2020: 2:45 PM-3:20 PM
Moderator:
Disclosures:
No relevant conflicts of interest to declare.

Torsten Haferlach, MD

Munich Leukemia Laboratory GmbH, Munich, Germany

Rashmi Kanagal-Shamanna, MD

Hematopathology and Molecular Diagnostics, MD Anderson Cancer Center, Houston, TX; Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

David M. Kurtz, MD, PhD

Stanford University, San Francisco, CA

John F Markham, PhD

Peter MacCallum Cancer Centre, Parkville, Australia

Manja Meggendorfer, PhD

Munich Leukemia Laboratory GmbH, Munich, Germany

Niamh Appleby, FRCPath(Haematology)

Oxford Molecular Diagnostics Centre, University of Oxford, Oxford, United Kingdom

Torsten Haferlach, MD

Munich Leukemia Laboratory GmbH, Munich, Germany